Caligan Partners’s Inventiva IVA Stock Holding History

Caligan Partners’s Portfolio IVA Stock Details IVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$27.6M	Buy	4,974,906 +2,974,906	+149%	+$18.1M	1.84%	17
2025 Q4	$9.3M	Buy	+2,000,000	New	+$9.29M	0.77%	20

Other funds holding IVA

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TECP

Trails Edge Capital Partners Atlanta, Georgia $437M AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SCP

SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Andera Partners Paris $177M AUM

Caligan Partners's IVA Position: Q1 2026 in Review

Caligan Partners increased its Inventiva (IVA) stake by 149% in Q1 2026, buying an estimated $18.1M and bringing the position to 4,974,906 shares worth $27.6M. The position accounts for 1.84% of the portfolio, ranked #17.

Caligan Partners first reported a position in IVA in Q4 2025 and has held it in 2 quarters since. 65 funds tracked by Wall St. Rank hold IVA as of Q1 2026.

Caligan Partners held 4,974,906 shares of Inventiva worth $27.6M as of Q1 2026.
Caligan Partners bought 2,974,906 Inventiva shares in Q1 2026, an estimated $18.1M.
Inventiva made up 1.84% of Caligan Partners's portfolio in Q1 2026, its #17 holding.
Caligan Partners first reported a position in Inventiva in Q4 2025 and has held it in 2 quarters since.
65 funds tracked by Wall St. Rank held Inventiva as of Q1 2026.

Based on Caligan Partners's 13F filing for Q1 2026, filed 15 May 2026.